A bill to limit cost sharing for prescription drugs, and for other purposes.

Bill 118 s 4671, also known as the Prescription Drug Cost Sharing Limitation Act, aims to address the rising costs of prescription drugs by placing limits on the amount that individuals are required to pay out of pocket for their medications. The bill seeks to make prescription drugs more affordable for all Americans, regardless of their income or insurance coverage.

Under this legislation, insurance companies would be prohibited from charging individuals more than a certain amount for their prescription drugs. This limit would apply to both brand-name and generic medications, ensuring that individuals are not burdened with exorbitant costs when trying to access necessary medications.

In addition to limiting cost sharing, the bill also includes provisions to increase transparency in drug pricing and promote competition in the pharmaceutical industry. By requiring drug manufacturers to disclose pricing information and encouraging the development of generic alternatives, the legislation aims to lower overall drug costs for consumers. Overall, the Prescription Drug Cost Sharing Limitation Act seeks to make prescription drugs more affordable and accessible for all Americans. By placing limits on cost sharing, increasing transparency, and promoting competition, the bill aims to address the root causes of high drug prices and ensure that individuals can access the medications they need without facing financial hardship.